|
Subscribe / Renew |
|
|
Contact Us |
|
| ► Subscribe to our Free Weekly Newsletter | |
| home | Welcome, sign in or click here to subscribe. | login |
| |
January 28, 2025

Schweitzer Engineering Laboratories (SEL) has expanded into medical devices with the production of a tool for detecting the likelihood of autism spectrum disorder. Dr. Georgina Lynch recently joined SEL as principal scientist after inventing and leading the development of a prototype while at Washington State University. Lynch holds a PhD in neuroscience/psychology and has a background in speech-language pathology and more than 20 years of experience working with children with autism. “We are excited about Dr. Lynch's invention, and delighted that we can further its development, pursue approvals and begin production,” said Edmund O. Schweitzer, III, SEL founder and chairman of the board of the Pullman-based laboratories. SEL has created a medical devices team to pursue this new technology. The device, which can detect an atypical pupil light reflex and the likelihood of autism within 24 months of birth, is a handheld tool to be used by clinicians during well-child exams. Lynch and her team are working through the FDA regulatory and compliance requirements. SEL, a 100% employee-owned company, invents, designs and builds digital products and systems that protect power grids around the world.